Inorganic arsenite-induced malignant transformation of human prostate epithelial cells

J Natl Cancer Inst. 2002 Dec 18;94(24):1888-91. doi: 10.1093/jnci/94.24.1888.

Abstract

Although several epidemiologic studies show an association between arsenic exposure and prostate cancer, it is still unknown whether human prostate epithelial cells are directly susceptible to arsenic-induced transformation. This study was designed to determine whether the nontumorigenic human prostate epithelial cell line RWPE-1 could be malignantly transformed in vitro by arsenite. RWPE-1 cells were continuously exposed to 5 micro M arsenite and monitored for signs of transformation, assessed as changes in matrix metalloproteinase-9 levels. After 29 weeks of exposure, the arsenite-exposed RWPE-1 cells (referred to as CAsE-PE) showed a marked increase in matrix metalloproteinase-9 secretion, a common finding in prostate malignancies. Malignant transformation was confirmed when CAsE-PE cells produced aggressive undifferentiated malignant epithelial tumors in nude mice. The tumors stained positive for human prostate-specific antigen, confirming their origin. These results are the first report of arsenite-induced malignant transformation of a human epithelial cell line and provide an important in vitro model for studying the mechanisms underlying arsenic-induced carcinogenesis in humans.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arsenites / adverse effects*
  • Carcinogens / adverse effects*
  • Cell Line / drug effects
  • Cell Transformation, Neoplastic / drug effects*
  • Humans
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Mice
  • Mice, Nude
  • Prostate / drug effects*
  • Prostate / enzymology
  • Prostate / immunology
  • Prostate / pathology*
  • Prostate-Specific Antigen / analysis
  • Urothelium / drug effects
  • Urothelium / pathology

Substances

  • Arsenites
  • Carcinogens
  • Prostate-Specific Antigen
  • Matrix Metalloproteinase 9
  • arsenite